LANSOFIX
MRP: 140
Packaging: 30 mg
Pack Type: injection
Composition:
Lansoprazole 30mg Injection
Indication:
Erosive esophagitis, Upper gastrointestinal bleeding due to peptic ulcers.
Description:
Lansoprazole 30mg Injection is a proton pump inhibitor (PPI) used to reduce gastric acid secretion in patients who are unable to take oral medication. It is indicated for the short-term treatment of acid-related disorders, including gastric and duodenal ulcers, gastroesophageal reflux disease (GERD), erosive esophagitis, and Zollinger-Ellison syndrome. By inhibiting the H⁺/K⁺ ATPase enzyme in gastric parietal cells, Lansoprazole effectively lowers acid production, promoting mucosal healing and symptom relief.
This injectable formulation provides rapid acid suppression and is often used in hospital or critical care settings.
Tags:
- Rapid suppression of gastric acid
- Effective for GERD, ulcers, and erosive esophagitis
- IV use when oral therapy is not suitable
- Promotes faster healing of gastrointestinal mucosa
- Can be used in critically ill or NPO (nothing by mouth) patients
Usage Information
Dosage
Route: Intravenous injection Typical Dose: 30mg once daily Administration: Injected slowly over 15 minutes or as per label Duration: Short-term use (usually 7–10 days) until oral therapy is resumed Administered only by trained medical personnel
Side Effects
Headache Nausea or vomiting Diarrhea or constipation Injection site reactions (pain, redness) Rare: Hypomagnesemia, vitamin B12 deficiency (with prolonged use) Allergic reactions (rare)
Contraindications
Known hypersensitivity to Lansoprazole or other PPIs Severe liver dysfunction (use with caution) Not recommended for long-term IV therapy Concomitant use with drugs like rilpivirine
Availability
Lansoprazole 30mg injection IV PPI for acid reflux Injection for gastric ulcer Lansoprazole injection uses Lansoprazole for GERD Hospital-use proton pump inhibitor Injectable treatment for acidity